Endocrinology Cardiology General Medicine A
Metabolic Syndrome Criteria (IDF 2006)
IDF 2006 criteria for metabolic syndrome. Central obesity is required plus ≥2 of 4 additional criteria.
References
- Alberti KG, et al. The metabolic syndrome — a new worldwide definition. Lancet. 2005;366(9491):1059-1062.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Ziprasidone · Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)
- Atorvastatin (CKD Cardiovascular Risk) · Cardiovascular Risk in CKD
- Icosapent Ethyl (Omega-3 — Cardiovascular Risk Reduction) · Omega-3 Fatty Acid (Purified EPA — Eicosapentaenoic Acid Ethyl Ester)
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Trimetazidine · Metabolic Anti-Anginal
- L-Carnitine · Antidote / Metabolic Agent
Pathways
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.